K252633 is an FDA 510(k) clearance for the UNITY DX (UDX). This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).
Submitted by Cylite Pty. , Ltd. (Mulgrave, AU). The FDA issued a Cleared decision on December 23, 2025, 125 days after receiving the submission on August 20, 2025.
This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..